Northwest Biotherapeutics, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NWBO Over the counter 8731 http://www.nwbio.com 0.24 Stock Down -0.01

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Northwest Biotherapeutics, Inc

NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5 Million of 2014 Bonds - Jun 22nd, 2017 9:41 am
Dr. Marnix Bosch To Present Updates About DCVax® Clinical Programs Today - Jun 5th, 2017 7:17 am
Northwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 - May 24th, 2017 7:26 am
Northwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q4, 2016 By the Numbers : April 20, 2017 - Apr 20th, 2017 11:30 am
Northwest Bio Receives SEC Subpoena and Other Awful Nuggets From New 10-K - Apr 18th, 2017 6:52 am
Northwest Bio Executive Pleads Ignorance about Clinical Trial Halt, Stock Collapse - Apr 4th, 2017 10:52 am
Novocure Glioblastoma Drug Offers Survival Benefits - Apr 3rd, 2017 9:40 am
FDA Allows Ziopharm's Brain Cancer Drug Trial - Mar 27th, 2017 11:19 am
NW Bio Has Closed On Its Registered Direct Offering Of $7.5 Million With Institutional Investors - Mar 23rd, 2017 10:49 am
NW BIO Announces Registered Direct Offering Of $7.5 Million - Mar 17th, 2017 7:00 am
Northwest Biotherapeutics agrees to pay bondholders $11 million, needs cash - Mar 16th, 2017 11:05 am
NW Bio Reaches Agreement With Convertible Note Holders - Mar 10th, 2017 6:15 am
FDA lifts hold on Northwest Bio’s brain cancer immunotherapy trial - Feb 9th, 2017 5:31 am
FDA Lifts Hold on Northwest Bio Cancer Drug Trial - Feb 7th, 2017 8:05 am
NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached - Feb 6th, 2017 7:30 am
NW Bio Presenting At Phacilitate Immunotherapy World Conference - Jan 18th, 2017 1:28 pm
ETFs with exposure to Northwest Biotherapeutics, Inc. : December 30, 2016 - Dec 30th, 2016 9:18 am
NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $10.0 MILLION WITH INSTITUTIONAL INVESTORS - Dec 20th, 2016 7:29 am